Newer insights into the management of interstitial lung disease in systemic sclerosis

Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now the leading cause of death in SSc patients, largely from progressive respiratory failure or advanced pulmonary hypertension. Despite significant advances in our understanding of the epidemiology and pa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Robert L Mango, Jay H Ryu, Ashima Makol
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2017-01-01
Col·lecció:	Indian Journal of Rheumatology
Matèries:	Antifibrotic treatment connective tissue diseases immunosuppressive agents interstitial lung disease interstitial lung diseases systemic sclerosis
Accés en línia:	http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=194;epage=203;aulast=Mango
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!